Basit öğe kaydını göster

dc.contributor.authorBeker, Mustafa Çağlar
dc.contributor.authorÇağlayan, Berrak
dc.contributor.authorÇağlayan, Ahmet Burak
dc.contributor.authorKelestemur, Taha
dc.contributor.authorYalçın, Esra
dc.contributor.authorÇağlayan, Aysun
dc.contributor.authorKılıç, Ülkan
dc.contributor.authorBaykal, Ahmet Tarık
dc.contributor.authorReiter, Russel J.
dc.contributor.authorKılıç, Ertuğrul
dc.date.accessioned2020-01-03T06:22:36Z
dc.date.available2020-01-03T06:22:36Z
dc.date.issued2019en_US
dc.identifier.citationBeker, M. Ç., Çağlayan, B., Çağlayan, A. B., Kelestemur, T., Yalçın, E., Çağlayan, A. ... Kılıç, E. (2019). Interaction of melatonin and Bmal1 in the regulation of PI3K/AKT pathway components and cellular survival. Scientific Reports, 9. https://doi.org/10.1038/s41598-019-55663-0en_US
dc.identifier.issn2045-2322
dc.identifier.urihttps://doi.org/10.1038/s41598-019-55663-0
dc.identifier.urihttps://hdl.handle.net/20.500.12511/4880
dc.description.abstractThe circadian rhythm is driven by a master clock within the suprachiasmatic nucleus which regulates the rhythmic secretion of melatonin. Bmal1 coordinates the rhythmic expression of transcriptome and regulates biological activities, involved in cell metabolism and aging. However, the role of Bmal1 in cellular- survival, signaling, its interaction with intracellular proteins, and how melatonin regulates its expression is largely unclear. Here we observed that melatonin increases the expression of Bmal1 and both melatonin and Bmal1 increase cellular survival after oxygen glucose deprivation (OGD) while the inhibition of Bmal1 resulted in the decreased cellular survival without affecting neuroprotective effects of melatonin. By using a planar surface immunoassay for PI3K/AKT signaling pathway components, we revealed that both melatonin and Bmal1 increased phosphorylation of AKT, ERK-1/2, PDK1, mTOR, PTEN, GSK-3 alpha beta, and p70S6K. In contrast, inhibition of Bmal1 resulted in decreased phosphorylation of these proteins, which the effect of melatonin on these signaling molecules was not affected by the absence of Bmal1 . Besides, the inhibition of PI3K/AKT decreased Bmal1 expression and the effect of melatonin on Bmal1 after both OGD in vitro and focal cerebral ischemia in vivo. Our data demonstrate that melatonin controls the expression of Bmal1 via PI3K/AKT signaling, and Bmal1 plays critical roles in cellular survival via activation of survival kinases.en_US
dc.language.isoengen_US
dc.publisherNature Publishing Groupen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectFocal Cerebral-Ischemiaen_US
dc.subjectClock Gene-Expressionen_US
dc.subjectCircadian-Rhythmen_US
dc.subjectBrain-Injuryen_US
dc.subjectMechanismsen_US
dc.subjectReceptorsen_US
dc.subjectSleepen_US
dc.subjectPhosphorylationen_US
dc.subjectHippocampusen_US
dc.subjectDisruptionen_US
dc.titleInteraction of melatonin and Bmal1 in the regulation of PI3K/AKT pathway components and cellular survivalen_US
dc.typearticleen_US
dc.relation.ispartofScientific Reportsen_US
dc.departmentİstanbul Medipol Üniversitesi, Rektörlük, Rejeneratif ve Restoratif Tıp Araştırmaları Merkezi (REMER)en_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Fizyoloji Ana Bilim Dalıen_US
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Biyoloji Ana Bilim Dalıen_US
dc.authorid0000-0002-9476-8488en_US
dc.authorid0000-0002-5072-132Xen_US
dc.authorid0000-0002-6242-3709en_US
dc.authorid0000-0003-3616-1204en_US
dc.authorid0000-0002-1064-7989en_US
dc.authorid0000-0001-6494-8923en_US
dc.identifier.volume9en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1038/s41598-019-55663-0en_US
dc.identifier.wosqualityQ1en_US
dc.identifier.scopusqualityQ1en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess